期刊
NATURE MEDICINE
卷 22, 期 11, 页码 1194-1196出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm1116-1194
关键词
-
The US Food and Drug Administration approved a muscular-dystrophy drug against the scientific advice of its own staff and advisors. Despite leadership's attempts to downplay the controversy, doubts now surround standards for accelerated approval.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据